4//SEC Filing
Reese Lou 4
Accession 0000899243-23-010755
CIK 0001851657other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:48 PM ET
Size
10.4 KB
Accession
0000899243-23-010755
Insider Transaction Report
Form 4
Vaxxinity, Inc.VAXX
Reese Lou
DirectorExecutive Chairman
Transactions
- Award
Stock Option (right to buy)
2023-03-07+61,607→ 61,607 totalExercise: $2.29Exp: 2033-03-07→ Class A Common Stock (61,607 underlying) - Award
Stock Option (right to buy)
2023-03-07+620,000→ 620,000 totalExercise: $2.29Exp: 2033-03-07→ Class A Common Stock (620,000 underlying) - Award
Stock Option (right to buy)
2023-03-07+301,188→ 301,188 totalExercise: $2.29Exp: 2033-03-07→ Class A Common Stock (301,188 underlying)
Footnotes (3)
- [F1]The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 48 equal monthly installments beginning on March 7, 2023.
- [F2]The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options are fully vested upon issuance. This one-time option grant was made in lieu of an annual cash bonus payment to Mr. Reese.
- [F3]The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 12 equal monthly installments beginning on January 1, 2023. The one-time option grant was made in consideration of Mr. Reese waiving his salary for fiscal years 2022 and 2023.
Documents
Issuer
Vaxxinity, Inc.
CIK 0001851657
Entity typeother
Related Parties
1- filerCIK 0001890674
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:48 PM ET
- Size
- 10.4 KB